Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Sarah Paul | Researchclopedia

Back to researchers

Sarah Paul

37

Works

1,968

Citations

13

h-index

13

i10-index

Research Topics

Cancer Genomics and Diagnostics Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations

Affiliations

Duquesne University2012–2012

PSG Institute of Medical Sciences & Research2001–2015

Washington University in St. Louis2022–2022

CancerCare2024–2024

Riverside Research Institute1998–1998

Top Works

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

David R. Gandara,Sarah Paul,et al.

20181,187 citations

Colorectal Cancer Treatments and Studies

Lymphoma Diagnosis and Treatment

Cold-Inducible Zfp516 Activates UCP1 Transcription to Promote Browning of White Fat and Development of Brown Fat

Jon Dempersmier,Audrey Sambeat,et al.

2015250 citations

LSD1 Interacts with Zfp516 to Promote UCP1 Transcription and Brown Fat Program

Audrey Sambeat,Оlga N. Gulyaeva,et al.

201699 citations

Blood-based biomarkers for cancer immunotherapy: Tumor mutational burden in blood (bTMB) is associated with improved atezolizumab (atezo) efficacy in 2L+ NSCLC (POPLAR and OAK)

David R. Gandara,Marcin Kowanetz,et al.

201784 citations

Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive Cohort

Rafał Dziadziuszko,Tony Mok,et al.

202159 citations

Association of high tissue TMB and atezolizumab efficacy across multiple tumor types.

Fatema A. Legrand,David R. Gandara,et al.

201857 citations

Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results.

Vamsidhar Velcheti,Edward S. Kim,et al.

201842 citations

Abstract 5706: A blood-based next-generation sequencing assay to determine tumor mutational burden (bTMB) is associated with benefit to an anti-PD-L1 inhibitor, atezolizumab

David Fabrizio,Daniel S. Lieber,et al.

201838 citations

Correlation of EEG, CT, and MRI brain with neurological outcome at 12 months in term newborns with hypoxic ischemic encephalopathy

John Matthai,Annu Jose,et al.

201337 citations